LogoThe Drop In by DoubleBlind
Upgrade
Subscribe Now
LogoThe Drop In by DoubleBlind

Archive

Did Oprah Just Mainstream Psychedelics?

Mar 6, 2025

•

17 min read

Did Oprah Just Mainstream Psychedelics?

Plus, all the tea on Amazonian snuff, destigmatizing coca, and so much more.

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Colorado Cities Push Back on Psilocybin Therapy Boom

Mar 5, 2025

•

10 min read

Colorado Cities Push Back on Psilocybin Therapy Boom

Colorado’s first psilocybin license is here, but cities are slowing the roll with moratoriums and tough zoning laws.

Randy Robinson
Randy Robinson
Are There Benefits to Feeling Shame and Guilt While Tripping?

Mar 3, 2025

•

14 min read

Are There Benefits to Feeling Shame and Guilt While Tripping?

Plus, everything you need to know about 4-AcO-DMT, Datura, and working out & microdosing

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Sparking Global Change Through Radical Community Living

Mar 2, 2025

•

20 min read

Sparking Global Change Through Radical Community Living

This hidden community has spent decades pioneering sustainability, adventure, and radical collaboration—quietly shaping the world.

Shelby Hartman
Shelby Hartman
Inside the Quest to Make “Plant-Based” MDMA

Feb 28, 2025

•

14 min read

Inside the Quest to Make “Plant-Based” MDMA

Is plant-based, fair-trade MDMA the future of psychedelic medicine...or just hype?

Michelle Lhooq
Michelle Lhooq
The Death Penalty for Drug Dealers Won’t Fix Anything

Feb 27, 2025

•

18 min read

The Death Penalty for Drug Dealers Won’t Fix Anything

PLUS, more news on a lack of BIPOC representation in psychedelic research and why closing your eyes makes you trip harder

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Ketamine Therapy for Teens with PTSD? Researchers Say Yes.

Feb 26, 2025

•

8 min read

Ketamine Therapy for Teens with PTSD? Researchers Say Yes.

Traditional PTSD treatments don’t always work for teens, but UW-Madison researchers are testing a brand new approach using ketamine.

Randy Robinson
Randy Robinson
Is ketamine to Silicon Valley what coke is to Wall Street?

Feb 24, 2025

•

13 min read

Is ketamine to Silicon Valley what coke is to Wall Street?

PLUS, an ode to author Tom Robbins, how to safely take GHB, and tips for spiritual detoxification.

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Psychedelics, Shabbat, and a New Jewish Counterculture

Feb 23, 2025

•

26 min read

Psychedelics, Shabbat, and a New Jewish Counterculture

A new generation of seekers is using psychedelics to revolutionize religion

Madison Margolin
Madison Margolin
Inside Instagram’s Censorship of Psychedelics

Feb 21, 2025

•

3 min read

Inside Instagram’s Censorship of Psychedelics

We spoke to a former Meta employee

Mattha Busby
Mattha Busby
Psychedelic church gets shut down in the Bay

Feb 20, 2025

•

16 min read

Psychedelic church gets shut down in the Bay

PLUS psychedelics impact on long covid and Mexico’s wildest psychedelic plant

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Why is pharmaceutical ketamine disappearing?

Feb 19, 2025

•

7 min read

Why is pharmaceutical ketamine disappearing?

New evidence shows pharmaceutical ketamine is vanishing from the supply chain, but where is it going?

Mattha Busby
Mattha Busby
1...1819202122...28
The Drop In by DoubleBlind

The Drop In by DoubleBlind

Your essential newsletter covering the world of psychedelics. Trusted by 100k+ readers.


Home

Account